Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis.
PMID:35326723
Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1.
PMID:35261797
Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer.
PMID:35222842
ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
PMID:35150321
Identification of neoantigens for individualized therapeutic cancer vaccines.
PMID:35105974
miR-4759 suppresses breast cancer through immune checkpoint blockade.
PMID:35024096
Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses.
PMID:34912802
Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
PMID:34803511
Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis.
PMID:34769200
Identification of Three Core Secretome Genes Associated with Immune Infiltration in High Tumor Mutation Burden Across 14 Major Solid Tumors.
PMID:34703282
Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.
PMID:34646087
Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma.
PMID:34589110
Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma.
PMID:34567061
Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.
PMID:34331382
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
PMID:34277633
CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
PMID:34258261
Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study.
PMID:34257617
Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.
PMID:34181336
Identifying Key Somatic Copy Number Alterations Driving Dysregulation of Cancer Hallmarks in Lower-Grade Glioma.
PMID:34163522
Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.
PMID:34149795
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma.
PMID:34141460
COSMIC Cancer Gene Census 3D database: understanding the impacts of mutations on cancer targets.
PMID:34137435
Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma.
PMID:34093661
driveR: a novel method for prioritizing cancer driver genes using somatic genomics data.
PMID:34030627
VWCE as a potential biomarker associated with immune infiltrates in breast cancer.
PMID:34020650
The microRNA-210-Stathmin1 Axis Decreases Cell Stiffness to Facilitate the Invasiveness of Colorectal Cancer Stem Cells.
PMID:33921319
Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma.
PMID:33869018
High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1.
PMID:33807275
Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.
PMID:33711952
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
PMID:33664854
Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks.
PMID:33613533
Artificial intelligence in cancer research: learning at different levels of data granularity.
PMID:33533192
Comprehensive analysis of glutathione peroxidase-1 (GPX1) expression and prognostic value in three different types of renal cell carcinoma.
PMID:33457246
Genomic and transcriptomic landscape of conjunctival melanoma.
PMID:33383577
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
PMID:33335254
Multi-Approach Bioinformatics Analysis of Curated Omics Data Provides a Gene Expression Panorama for Multiple Cancer Types.
PMID:33329726
Integration of Online Omics-Data Resources for Cancer Research.
PMID:33193699
OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
PMID:33179738
Systems Biology and Experimental Model Systems of Cancer.
PMID:33086677
GMIEC: a shiny application for the identification of gene-targeted drugs for precision medicine.
PMID:32912170
microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma.
PMID:32848463
Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling.
PMID:32714870
Identification and Analysis of p53-Regulated Enhancers in Hepatic Carcinoma.
PMID:32695760
Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools.
PMID:32695678
Dissecting the Functional Mechanisms of Somatic Copy-Number Alterations Based on Dysregulated ceRNA Networks across Cancers.
PMID:32668393
Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy.
PMID:32543783
Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics.
PMID:32411775
Expression and prognostic potential of GPX1 in human cancers based on data mining.
PMID:32175417
Identification of Prognostic Dosage-Sensitive Genes in Colorectal Cancer Based on Multi-Omics.
PMID:31998369